The choice of treatment therapies depends on the types of breast cancer, including triple-negative breast cancer, HER2 (human epidermal growth factor receptor 2)-negative cancer, and hormone receptor (HR)-positive breast cancer, and HER1-positive diseases [67]. This evidence concerns the gene NR4A1 and breast cancer.